An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
1 other identifier
interventional
1,559
2 countries
118
Brief Summary
The objective of this study is to assess the long-term safety of linaclotide administered to patients with chronic constipation (CC) or irritable bowel syndrome with constipation (IBS-C).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Oct 2008
Typical duration for phase_3
118 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 1, 2008
CompletedFirst Posted
Study publicly available on registry
October 3, 2008
CompletedStudy Start
First participant enrolled
October 31, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2012
CompletedResults Posted
Study results publicly available
February 15, 2019
CompletedFebruary 15, 2019
January 1, 2019
3.3 years
October 1, 2008
September 19, 2017
January 24, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With at Least One Treatment-Emergent Adverse Events (TEAEs)
An AE is any untoward medical occurrence in a clinical study participant administered study drug. An AE could, therefore, be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of the study drug, whether or not related to the medicinal product. An AE that occurred during the treatment period was defined as a TEAE if the AE was either not present at, or before, the day of the first dose of open-label study medication in this study or was present at, or before, the day of the first dose of open-label study medication in this study and increased in severity during the treatment period. AEs included abnormal clinically significant findings for clinical laboratory tests, physical examination findings, vital sign measurements and electrocardiograms (ECGs).
Up to 78 weeks for AEs; within 30 days of last dose of study drug (up to 82 weeks) for serious AEs.
Study Arms (1)
Linaclotide
EXPERIMENTALLinaclotide 290 μg/day capsules, administered orally once daily for up to 78 weeks in participants with either CC or IBS-C. Dose reduction to 145 μg/day was permitted at the discretion of the Investigator if a participant experienced AEs intolerable enough to prompt consideration of study withdrawal. After a temporary suspension of dosing, participants may have received either 145 μg/day or 290 μg/day of linaclotide, at the discretion of the Investigator. Subsequent dose adjustments (increases or decreases between 290 μg/day and 145 μg/day) were permitted also at the Investigator's discretion.
Interventions
Linaclotide capsules, oral, once daily each morning at least 30 minutes before breakfast for the duration of the study.
Eligibility Criteria
You may qualify if:
- Patients must have
- entered study LIN-MD 01\[NCT00765882\] or LIN-MD-31 \[NCT00948818\] and at minimum completed the pre-treatment period or
- completed one of the following studies: MCP-103-004 \[NCT00306748\], MCP-103-005 \[NCT00258193\], MCP-103-201 \[NCT00402337\], MCP-103-202 \[NCT00460811\]
- Sexually active patients of childbearing potential agree to use birth control
- Females of childbearing potential must have a negative urine pregnancy test prior to dosing
- Lactating females must agree not to breastfeed
- Patient must meet protocol criteria for CC or IBS-C
You may not qualify if:
- Patient must not use protocol-defined prohibited medicine
- Patient is planning to receive an investigational drug at any time during the study
- Patient has an unresolved AE or a clinically significant finding on a physical examination, 12-lead ECG, or clinical laboratory test
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Forest Laboratorieslead
- Ironwood Pharmaceuticals, Inc.collaborator
Study Sites (118)
Innovative Clinical Trials
Birmingham, Alabama, 35205, United States
Parkway Medical Center
Birmingham, Alabama, 35215, United States
Medical Affiliated Research Center, Inc.
Huntsville, Alabama, 35801, United States
Radiant Research, Inc.
Chandler, Arizona, 85224, United States
Pivotal Research Centers
Peoria, Arizona, 85381, United States
Pivotal Research Center
Peoria, Arizona, 85381, United States
Carl T Hayden VA Medical Center GI Section-CS-111G
Phoenix, Arizona, 85012, United States
Elite Clinical Studies, LLC
Phoenix, Arizona, 85018, United States
Radiant Research, Inc.
Scottsdale, Arizona, 85251, United States
Genova Clinical Research, Inc.
Tucson, Arizona, 85704, United States
Adobe Clinical Research, LLC
Tucson, Arizona, 85712, United States
Providence Clinical Research
Burbank, California, 91505, United States
Encompass Clinical Research North Coast
Encinitas, California, 92024, United States
Family Medical Center
Foothill Ranch, California, 92610, United States
Axis Clinical Trials
Los Angeles, California, 90036, United States
Facey Medical Foundation
Mission Hills, California, 91345, United States
Advanced Clinical Research Institute
Orange, California, 92869, United States
Westlake Medical Research
Westlake Village, California, 91361, United States
Boulder Medical Center, P.C.
Boulder, Colorado, 80304, United States
Lynn Institute of the Rockies
Colorado Springs, Colorado, 80907, United States
Colorado Gastroenterology, Prof LLC
Denver, Colorado, 80205, United States
Longmont Medical Research Network
Longmont, Colorado, 80501, United States
Western States Clinical Research
Wheat Ridge, Colorado, 80033, United States
Chase Medical Research, LLC
Waterbury, Connecticut, 06708, United States
Clinical Trials Management of Boca Raton, Inc.
Boca Raton, Florida, 33428, United States
Meridien Research
Bradenton, Florida, 34208, United States
PAB Clinical Research
Brandon, Florida, 33511, United States
Meridien Research
Brooksville, Florida, 34601, United States
Clinical Physiology Associates Clinical Study Center
Fort Myers, Florida, 33916, United States
Jupiter Research, Inc.
Jupiter, Florida, 33458, United States
FPA Clinical Research
Kissimmee, Florida, 34741, United States
Pharmax Research Clinic
Miami, Florida, 33126, United States
United Medical Research
New Smyrna Beach, Florida, 32168, United States
RenStar Medical Research
Ocala, Florida, 34471, United States
Compass Research
Orlando, Florida, 32806, United States
Emerald Coast Research Associates
Panama City, Florida, 32405, United States
University Clinical Research, Inc.
Pembroke Pines, Florida, 33024, United States
Miami Research Associates
South Miami, Florida, 33143, United States
Meridien Research
St. Petersburg, Florida, 33709, United States
Meridien Research
Tampa, Florida, 33606, United States
Advanced Research Institute
Trinity, Florida, 34655, United States
Florida Medical Clinic, P.A. Clinical Research Division
Zephyrhills, Florida, 33542, United States
Radiant Research, Inc.
Atlanta, Georgia, 30342, United States
Gastrointestinal Specialists of Georgia, PC
Marietta, Georgia, 30060, United States
Atlanta Gastroenterology Associates, LLC
Marietta, Georgia, 30067, United States
Clinical Research Atlanta
Stockbridge, Georgia, 30281, United States
North Georgia Clinical Research
Woodstock, Georgia, 30189, United States
Rosemark WomenCare Specialist
Idaho Falls, Idaho, 83404, United States
Rockford Gastroenterology Associates, Ltd.
Rockford, Illinois, 61107, United States
MediSphere Medical Research Center, LLC
Evansville, Indiana, 47714, United States
University of Iowa Hospitals & Clinics
Iowa City, Iowa, 52242, United States
Heartland Research Associates, LLC
Arkansas City, Kansas, 67005, United States
Heartland Research Associates, LLC
Newton, Kansas, 67114, United States
Heartland Research Associates, LLC
Wichita, Kansas, 67205, United States
Heartland Research Associates, LLC
Wichita, Kansas, 67207, United States
Central Kentucky Research Associates
Lexington, Kentucky, 40509, United States
Trover Health System
Madisonville, Kentucky, 42431, United States
Medical Development Centers, LLC
Baton Rouge, Louisiana, 70808, United States
Clinical Trials of America, Inc.
Shreveport, Louisiana, 71101, United States
Metropolitan Gastroenterology Group PC, Chevy Chase Clinical Research
Chevy Chase, Maryland, 20815, United States
Meritus Center for Clinical Research
Hagerstown, Maryland, 21742, United States
Charm City Research
Towson, Maryland, 21286, United States
Boston Clinical Trials
Boston, Massachusetts, 02135, United States
Kalamazoo Gastroenterology Hepatology
Kalamazoo, Michigan, 49048, United States
Ridgeview Research Two Twelve Medical Center
Chaska, Minnesota, 55318, United States
St. Louis Center for Clinical Research
St Louis, Missouri, 63128, United States
The Gastroenterology Group of S.J.
Vineland, New Jersey, 08360, United States
New Mexico Clinical Research and Osteoporosis Center
Albuquerque, New Mexico, 87106, United States
Lifeline Research Institute
Brooklyn, New York, 11214, United States
Long Island Clinical Research Associates, LLP
Great Neck, New York, 11021, United States
Long Island Gastrointestinal Research Group
Great Neck, New York, 11023, United States
Gastrointestinal Research Associates, LLC
Setauket, New York, 11733, United States
MediSpect, LLC
Boone, North Carolina, 28607, United States
Cumberland Research Associates, LLC
Fayetteville, North Carolina, 28304, United States
LeBauer Research Associates, P.A.
Greensboro, North Carolina, 27403, United States
Clinical Trials of America, INC
Hickory, North Carolina, 28601, United States
Wake Research Associates, LLC
Raleigh, North Carolina, 27612, United States
Hanover Medical Specialists, PA
Wilmington, North Carolina, 28401, United States
Digestive Health Specialists, PA
Winston-Salem, North Carolina, 27103, United States
Consultants for Clinical Research
Cincinnati, Ohio, 45219, United States
Rapid Medical Research, Inc.
Cleveland, Ohio, 44122, United States
Remington Davis
Columbus, Ohio, 43215, United States
Hometown Urgent Care and Research
Dayton, Ohio, 45432, United States
Oklahoma Foundation for Digestive Research
Oklahoma City, Oklahoma, 73104, United States
Gastroenterology United of Tulsa
Tulsa, Oklahoma, 74135, United States
Clinical Trials Research Services, LLC
Pittsburgh, Pennsylvania, 15206, United States
Upstate Pharmaceutical Research
Greenville, South Carolina, 29615, United States
Mountain View Clinical Research
Greer, South Carolina, 29651, United States
Radiant Research
Greer, South Carolina, 29651, United States
Nashville Medical Research Institute
Nashville, Tennessee, 37205, United States
Professional Quality Research, Inc.
Austin, Texas, 78705, United States
Research Across America RHD Professional Plaza IV
Dallas, Texas, 75234, United States
Houston Digestive Diseases Clinic
Houston, Texas, 77090, United States
Houston Medical Research Associates
Houston, Texas, 77090, United States
R/D Clinical Research, Inc.
Lake Jackson, Texas, 77566, United States
Quality Research Inc.
San Antonio, Texas, 78209, United States
Diagnostics Research Group
San Antonio, Texas, 78229, United States
Fatigue Consultation Clinic
Salt Lake City, Utah, 84102, United States
Department of Gastroenterology University of Utah Hospital
Salt Lake City, Utah, 84132, United States
Department of Veterans Affairs Research Department
Salt Lake City, Utah, 84148, United States
Charlottesville Medical Research
Charlottesville, Virginia, 22911, United States
New River Valley Research Institute
Christiansburg, Virginia, 24073, United States
Health Research of Hampton Roads
Newport News, Virginia, 23606, United States
National Clinical Research - Norfolk, Inc.
Norfolk, Virginia, 23502, United States
Clinical Research Associates of Tidewater
Norfolk, Virginia, 23507, United States
National Clinical Research-Richmond, Inc.
Richmond, Virginia, 23294, United States
Northwest Gastroenterology Associates
Bellevue, Washington, 98004, United States
Radiant Research, Inc.
Lakewood, Washington, 98499, United States
Wenatchee Valley Medical Center Clinical Research Dept.
Wenatchee, Washington, 98801, United States
Aurora Advanced Healthcare, Inc. Clinical Research Center
Milwaukee, Wisconsin, 53209, United States
GI Research Institute
Vancouver, British Columbia, V6Z 2K5, Canada
Medicor Research, Inc.
Greater Sudbury, Ontario, P3E 1H5, Canada
St. Joseph Healthcare
Hamilton, Ontario, L8N 4A6, Canada
MedPhase Canada
Newmarket, Ontario, L3Y 8E4, Canada
Meadowlands Family Health Center
Ottawa, Ontario, K2C 3R2, Canada
London Road Diagnostic Clinic and Medical Center
Sarnia, Ontario, N7T 4X3, Canada
PrimeHealth Clinical Research
Toronto, Ontario, M4S 1Y2, Canada
Toronto Digestive Disease Associates, Inc.
Vaughan, Ontario, L4L 4Y7, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Vice President, Clinical Development, Gastrointestinal
- Organization
- Allergan, Inc.
Study Officials
- STUDY DIRECTOR
Paul Eng, PhD
Forest Laboratories
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2008
First Posted
October 3, 2008
Study Start
October 31, 2008
Primary Completion
January 31, 2012
Study Completion
January 31, 2012
Last Updated
February 15, 2019
Results First Posted
February 15, 2019
Record last verified: 2019-01